191 followers
RT @NatureBiotech: Our 2Q20 drug pipeline Data Page shows @US_FDA accelerated approvals for cancer indications, including two small molecul…
RT @NatureBiotech: Our 2Q20 drug pipeline Data Page shows @US_FDA accelerated approvals for cancer indications, including two small molecul…
RT @NatureBiotech: Our 2Q20 drug pipeline Data Page shows @US_FDA accelerated approvals for cancer indications, including two small molecul…
Our 2Q20 drug pipeline Data Page shows @US_FDA accelerated approvals for cancer indications, including two small molecules — @Incyte’s #Pemazyre and @Novartis’s @TABRECTA_US — approved with companion diagnostics from @FoundationATCG https://t.co/ubNlimmAQc
Drug pipeline 2Q20 | Nature Biotechnology https://t.co/QYrNSpyjXA